Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 14Breast Neoplasms 14Neoplasms 10Head and Neck Neoplasms 8Carcinoma, Squamous Cell 8Lung Neoplasms 7Leukemia, Myeloid, Acute 7Glioblastoma 7Colorectal Neoplasms 7Ovarian Neoplasms 6Neoplasm Metastasis 6Recurrence 5Pancreatic Neoplasms 5Melanoma 5Leukemia 5Prostatic Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, Non-Hodgkin 4Fallopian Tube Neoplasms 4Anemia, Refractory, with Excess of Blasts 4Squamous Cell Carcinoma of Head and Neck 3Small Cell Lung Carcinoma 3Rectal Neoplasms 3Lymphoma, Follicular 3Colonic Neoplasms 3Brain Neoplasms 3Treatment 2Sarcoma 2Pleural Effusion, Malignant 2Pharyngeal Neoplasms 2

Interventions

trametinib 1dehydroftorafur 1Sorafenib 1Self Expandable Metallic Stents 1Leucovorin 1Gemcitabine 1Fluorouracil 1Erlotinib Hydrochloride 1Drug Therapy 1Cisplatin 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Klatskin Tumor × Drug Therapy × Clear all
NCT02082522 2019-08-28

Efficacy and Safety Study of PDT Using Photofrin in Unresectable Advanced Perihilar Cholangiocarcinoma (OPUS)

Concordia Laboratories Inc.

Phase 3 Terminated
28 enrolled 24 charts
Gastrointestinal

Bile Duct Neoplasms, Cholangiocarcinoma, Klatskin Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡